GeneBlocs Are Powerful Tools to Study and Delineate Signal Transduction Processes That Regulate Cell Growth and Transformation
- 1 June 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 12 (3) , 131-143
- https://doi.org/10.1089/108729002760220734
Abstract
The study of signal transduction processes using antisense oligonucleotides is often complicated by low intracellular stability of the antisense reagents or by nonspecific effects that cause toxicity. Here, we introduce a new class of antisense molecules, so-called GeneBlocs, which are characterized by improved stability, high target RNA specificity, and low toxicity. GeneBlocs allow for efficient downregulation of mRNA expression at nanomolar concentrations, and they do not interfere with cell proliferation. We demonstrate these beneficial properties using a positive readout system. GeneBloc-mediated inhibition of tumor suppressor PTEN (phosphatase and tension homologue detected on chromosome 10) expression leads to hyperactivation of the phosphatidylinositol (PI) 3-kinase pathway, thereby mimicking the loss of PTEN function and its early consequences observed in mammalian cancer cells. Specifically, cells treated with PTEN GeneBlocs show functional activation of Akt, a downstream effector of PI 3-kinase signaling, and exhibit enhanced proliferation when seeded on a basement membrane matrix. In addition, GeneBlocs targeting the catalytic subunit of PI 3-kinase, p110, specifically inhibit signal transduction of endogenous or recombinant PI 3-kinase. This demonstrates that GeneBlocs are powerful tools to analyze and to modulate signal transduction processes and, therefore, represent alternative reagents for the validation of gene function.Keywords
This publication has 39 references indexed in Scilit:
- Gatekeeper for endometrium: the PTEN tumor suppressor gene.JNCI Journal of the National Cancer Institute, 2000
- New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathwayProceedings of the National Academy of Sciences, 1999
- Antisense therapeuticsCurrent Opinion in Chemical Biology, 1998
- Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activationBiochemical Journal, 1998
- Mixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In VivoAntisense and Nucleic Acid Drug Development, 1998
- Antisense oligonucleotides: Is the glass half full or half empty?Biochemical Pharmacology, 1998
- Chemical Modification of Hammerhead RibozymesJournal of Biological Chemistry, 1995
- Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agentsCellular and Molecular Neurobiology, 1994
- Rate of degradation of [α]- and [β]-oligodeoxynucleotides inXenopusoocytes. Implications for anti-messenger strategiesNucleic Acids Research, 1987
- Heterotransplantation studies with tissue culture cell lines in various animal and in vitro host systemsJournal of Biological Standardization, 1985